Showing results (21-30 of 3,094) with videos related to
Sort By:
Pageof 310
Expert Review of Anticancer Therapy|February 9, 2016
Imatinib mesylate in chronic myeloid leukemia: frontline treatment and long-term outcomesFabio Stagno, Stefania Stella, Antonio Spitaleri, et al.Expert Review of Anticancer Therapy|May 25, 2016
The safety and efficacy of Onivyde (irinotecan liposome injection) for the treatment of metastatic pancreatic cancer following gemcitabine-based therapyFrank C Passero, Dimitra Grapsa, Kostas N Syrigos, et al.Expert Review of Anticancer Therapy|June 3, 2016
Biology and management of clear cell sarcoma: state of the art and future perspectivesJasmien Cornillie, Thomas van Cann, Agnieszka Wozniak, et al.Expert Review of Anticancer Therapy|March 4, 2016
Medication adherence to oral anticancer drugs: systematic reviewWen-Chuan Huang, Chung-Yu Chen, Shun-Jin Lin, et al.Expert Review of Anticancer Therapy|November 8, 2017
New targets and therapies for gastrointestinal stromal tumorsAgnieszka Wozniak, Yemarshet K Gebreyohannes, Maria Debiec-Rychter, et al.Expert Review of Anticancer Therapy|August 4, 2016
Preventing recurrence of diffuse malignant peritoneal mesotheliomaJoshua C Leinwand, John A Chabot, Michael D KlugerExpert Review of Anticancer Therapy|July 22, 2015
Emerging therapeutic options for Waldenström macroglobulinemia/lymphoplasmacytic lymphomaRajshekhar Chakraborty, Prashant Kapoor, Stephen M Ansell, et al.Expert Review of Anticancer Therapy|June 5, 2015
Low-grade serous carcinoma: molecular features and contemporary treatment strategiesAna M Angarita, Diana Cholakian, Amanda N FaderExpert Review of Anticancer Therapy|February 7, 2025
Nomograms for predicting overall and cancer-specific survival among patients with prostatic ductal adenocarcinoma: a population-base studyZhan Zhao, QianSan ZhuExpert Review of Anticancer Therapy|February 7, 2025
Disparities in consent to adjuvant radiotherapy in primary glioblastoma: a population-based studyWang Miao, Liu Yang, Jinhu Li, et al.Pageof 310